List of Excipients in API ELETRIPTAN HYDROBROMIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ELETRIPTAN HYDROBROMIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ROERIG | RELPAX | eletriptan hydrobromide | 0049-2330 | ALUMINUM OXIDE | |
| ROERIG | RELPAX | eletriptan hydrobromide | 0049-2330 | CELLULOSE, MICROCRYSTALLINE | |
| ROERIG | RELPAX | eletriptan hydrobromide | 0049-2330 | CROSCARMELLOSE SODIUM | |
| ROERIG | RELPAX | eletriptan hydrobromide | 0049-2330 | FD&C YELLOW NO. 6 | |
| ROERIG | RELPAX | eletriptan hydrobromide | 0049-2330 | HYPROMELLOSE | |
| ROERIG | RELPAX | eletriptan hydrobromide | 0049-2330 | LACTOSE MONOHYDRATE | |
| ROERIG | RELPAX | eletriptan hydrobromide | 0049-2330 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ELETRIPTAN HYDROBROMIDE
Detailed excipient profiles for ELETRIPTAN HYDROBROMIDE
Excipient focus: ALUMINUM OXIDE
ELETRIPTAN HYDROBROMIDE drug variants containing ALUMINUM OXIDE
ELETRIPTAN HYDROBROMIDE drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS LACTOSE
ELETRIPTAN HYDROBROMIDE drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eletriptan hydrobromide | 0378-4287 |
| Zydus Pharmaceuticals USA Inc | eletriptan hydrobromide | 68382-922 |
| Zydus Lifesciences Limited | eletriptan hydrobromide | 70771-1107 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ELETRIPTAN HYDROBROMIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
ELETRIPTAN HYDROBROMIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
ELETRIPTAN HYDROBROMIDE drug variants containing CROSCARMELLOSE SODIUM
ELETRIPTAN HYDROBROMIDE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
ELETRIPTAN HYDROBROMIDE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | eletriptan hydrobromide | 68382-922 |
| Zydus Lifesciences Limited | eletriptan hydrobromide | 70771-1107 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 2
ELETRIPTAN HYDROBROMIDE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | eletriptan hydrobromide | 65162-042 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
ELETRIPTAN HYDROBROMIDE drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | eletriptan hydrobromide | 68382-922 |
| Zydus Lifesciences Limited | eletriptan hydrobromide | 70771-1107 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C YELLOW NO. 5
ELETRIPTAN HYDROBROMIDE drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | eletriptan hydrobromide | 65162-042 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
ELETRIPTAN HYDROBROMIDE drug variants containing FD&C YELLOW NO. 6
ELETRIPTAN HYDROBROMIDE drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | eletriptan hydrobromide | 65162-042 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ELETRIPTAN HYDROBROMIDE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| ROERIG | eletriptan hydrobromide | 0049-2330 |
| Viatris Specialty LLC | eletriptan hydrobromide | 58151-367 |
| Greenstone LLC | eletriptan hydrobromide | 59762-2321 |
| US Pharmaceuticals | eletriptan hydrobromide | 63539-234 |
| Bryant Ranch Prepack | eletriptan hydrobromide | 71335-1830 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
ELETRIPTAN HYDROBROMIDE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | eletriptan hydrobromide | 0093-8310 |
| Aurobindo Pharma Limited | eletriptan hydrobromide | 59651-104 |
| Bryant Ranch Prepack | eletriptan hydrobromide | 63629-8320 |
| Advanced Rx of Tennessee LLC | eletriptan hydrobromide | 80425-0408 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
ELETRIPTAN HYDROBROMIDE drug variants containing HYPROMELLOSES
ELETRIPTAN HYDROBROMIDE drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
ELETRIPTAN HYDROBROMIDE drug variants containing LACTOSE
ELETRIPTAN HYDROBROMIDE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
ELETRIPTAN HYDROBROMIDE drug variants containing LACTOSE MONOHYDRATE
ELETRIPTAN HYDROBROMIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
ELETRIPTAN HYDROBROMIDE drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eletriptan hydrobromide | 0378-4287 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
ELETRIPTAN HYDROBROMIDE drug variants containing MAGNESIUM STEARATE
ELETRIPTAN HYDROBROMIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
ELETRIPTAN HYDROBROMIDE drug variants containing MICROCRYSTALLINE CELLULOSE 112
ELETRIPTAN HYDROBROMIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 112
Excipient focus: POLYDEXTROSE
ELETRIPTAN HYDROBROMIDE drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | eletriptan hydrobromide | 0093-8310 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL 8000
ELETRIPTAN HYDROBROMIDE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | eletriptan hydrobromide | 0093-8310 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
ELETRIPTAN HYDROBROMIDE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eletriptan hydrobromide | 0378-4287 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE K30
ELETRIPTAN HYDROBROMIDE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | eletriptan hydrobromide | 68382-922 |
| Zydus Lifesciences Limited | eletriptan hydrobromide | 70771-1107 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
ELETRIPTAN HYDROBROMIDE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | eletriptan hydrobromide | 0093-8310 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing SILICON DIOXIDE
Excipient focus: TALC
ELETRIPTAN HYDROBROMIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eletriptan hydrobromide | 0378-4287 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ELETRIPTAN HYDROBROMIDE drug variants containing TITANIUM DIOXIDE
ELETRIPTAN HYDROBROMIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
ELETRIPTAN HYDROBROMIDE drug variants containing TRIACETIN
ELETRIPTAN HYDROBROMIDE drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eletriptan hydrobromide | 0378-4287 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
ELETRIPTAN HYDROBROMIDE drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eletriptan hydrobromide | 0378-4287 |
| >Company | >Ingredient | >NDC |
ELETRIPTAN HYDROBROMIDE drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
